Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)

Condition:   AllergiesInterventions:   Drug: Desloratadine;   Drug: Zyrtec® (cetirizine)Sponsor:   Merck Sharp & Dohme Corp.Completed - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials